Connor, Clark & Lunn Investment Management (CC&L)
TMDX icon

Connor, Clark & Lunn Investment Management (CC&L)’s Transmedics TMDX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-74,625
Closed -$11.7M – 1639
2024
Q3 		$11.7M Buy
74,625
+64,872
+665% +$10M 0.06% 243
2024
Q2 		$1.47M Buy
+9,753
New +$1.17M 0.01% 747
2024
Q1 		– Sell
-27,148
Closed -$2.14M – 1707
2023
Q4 		$2.14M Sell
27,148
-5,085
-16% -$307K 0.01% 649
2023
Q3 		$1.76M Sell
32,233
-5,521
-15% -$397K 0.01% 649
2023
Q2 		$3.17M Buy
37,754
+9,730
+35% +$745K 0.02% 489
2023
Q1 		$2.12M Buy
+28,024
New +$1.94M 0.01% 537

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s TMDX Position: Q4 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Transmedics (TMDX) in Q4 2024, closing a stake of 74,625 shares — an estimated $11.7M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in TMDX in Q1 2023 and held it in 6 quarters. The position peaked at $11.7M in Q3 2024. 315 funds tracked by Wall St. Rank hold TMDX as of Q4 2024.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Transmedics position as of Q4 2024 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 74,625 Transmedics shares in Q4 2024, an estimated $11.7M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Transmedics in Q1 2023 and held it in 6 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Transmedics position peaked at $11.7M in Q3 2024.
  • 315 funds tracked by Wall St. Rank held Transmedics as of Q4 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2024, filed 10 Feb 2025.